Showing results (601-610 of 631) with videos related to
Sort By:
Pageof 64
Hematology, Transfusion and Cell Therapy|October 4, 2024
Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi MethodAstrid Pavlovsky, Juan Ignacio Garcia Altuve, Amalia Cerutti, et al.Hematology, Transfusion and Cell Therapy|September 25, 2024
Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, et al.Hematology, Transfusion and Cell Therapy|September 22, 2024
Performance and safety of therapeutic erythrocytapheresis in polycythemia and hemochromatosis treatment: single centre experienceIva Lucija Burnać, Ines Bojanić, Sanja Mazić, et al.Hematology, Transfusion and Cell Therapy|September 22, 2024
Psychological aspects in young people with venous thromboembolic disease, preliminary reportAlejandro Godoy, N Bula Galli, Aldo TabaresHematology, Transfusion and Cell Therapy|September 28, 2024
Early bacteremia following allogeneic hematopoietic stem cell transplantation without antibiotic prophylaxis: epidemiology and antimicrobial resistanceNour Ben Abdeljelil, Rihab Ouerghi, Insaf Ben Yaiche, et al.Hematology, Transfusion and Cell Therapy|September 11, 2024
From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapyFrank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, et al.Hematology, Transfusion and Cell Therapy|June 5, 2023
Impact of waitlist time on post-HSCT survival: a cohort study at a hospital in southern BrazilTatiana Schnorr Silva, Jaqueline Driemeyer Correia Horvath, Mariana Pinto Pereira, et al.Hematology, Transfusion and Cell Therapy|May 27, 2023
Human leukocyte antigen immunization in transfusion-dependent Moroccan patients with beta-thalassemia major: prevalence and risk factorsSanae Ouadghiri, Kaoutar El Morabit, Naoual Elansari, et al.Hematology, Transfusion and Cell Therapy|February 22, 2026
Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance?Musab Ma Omar, Majed A Alanazi, Denise E JacksonHematology, Transfusion and Cell Therapy|October 23, 2024
A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemiaMaryam Aghasipour, Fatemeh Asadian, Seyed Alireza Dastgheib, et al.Pageof 64